ArticleCancers2023
Development of a Machine Learning Model to Predict Recurrence of Oral Tongue Squamous Cell Carcinoma.
Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.
- Machine learning based prediction of recurrence in oral tongue cancer: a systematic review with quantitative synthesis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026Pooled it
- Prognosing post-treatment outcomes of head and neck cancer using structured data and machine learning: A systematic review.PloS one · 2024Pooled it
- Clinician-accessible automated machine learning in oral healthcare: A systematic review.The Japanese dental science review · 2026Review
- Performance of Machine Learning Models for Prognosis Prediction in Oral Cavity Squamous Cell Carcinoma: A Systematic Review.Cancers · 2026Review
- Artificial intelligence and its application in early oral cancer screening: a systematic review.Frontiers in oncology · 2026Review
- Review
- MRI in Oral Tongue Squamous Cell Carcinoma: A Radiomic Approach in the Local Recurrence Evaluation.Current oncology (Toronto, Ont.) · 2025Article
- Oral squamous cell carcinoma grading classification using deep transformer encoder assisted dilated convolution with global attention.Frontiers in artificial intelligence · 2025Article
- Establishment and validation of a recurrence risk model in early-stage tongue squamous cell carcinoma patients incorporating immune-inflammatory biomarkers and clinicopathological parameters.American journal of cancer research · 2025Article
- Deep transfer learning with improved crayfish optimization algorithm for oral squamous cell carcinoma cancer recognition using histopathological images.Scientific reports · 2024Article
- Artificial Intelligence in Head and Neck Cancer: Innovations, Applications, and Future Directions.Current oncology (Toronto, Ont.) · 2024Review
- Oral squamous cell carcinoma detection using EfficientNet on histopathological images.Frontiers in medicine · 2023Article
- Is ChatGPT accurate and reliable in answering questions regarding head and neck cancer?Frontiers in oncology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
Despite diagnostic advancements, the development of reliable prognostic systems for assessing the risk of cancer recurrence still remains a challenge. In this study, we developed a novel framework to generate highly representative machine-learning prediction models for oral tongue squamous cell carcinoma (OTSCC) cancer recurrence. We identified cases of 5- and 10-year OTSCC recurrence from the SEER database. Four classification models were trained using the H
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.